Description

Natamycin ophthalmic suspension is contraindicated in individuals with a history of hypersensitivity to any of its component.

Eye irritation, eye discomfort, eye edema, conjunctival chemosis and hyperemia has been reported.

Pregnancy Category C. Natamycin sterile ophthalmic suspension should be given to a pregnant woman only if clearly needed. Lactation: It is not known whether this drug is excreted in human milk. Caution should be exercised when Natamycin is administered to a nursing mother.

For topical eye use only. Failure of improvement of keratitis following 7-10 days of administration of the drug suggests that the infection may be caused by a microorganism not susceptible to natamycin.

Pediatric: Safety and effectiveness in paediatric patients have not been established.

Ophthalmic antibacterial drugs